Ozurdex for Retinal Vein Occlusion Study (ORVO Study).
Phase of Trial: Phase II/III
Latest Information Update: 01 Aug 2015
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal oedema; Retinal vein occlusion
- Focus Therapeutic Use
- Acronyms ORVO
- 05 May 2015 New trial record
- 02 Apr 2015 Status change from active, not recruiting to completed, as per ClinicalTrials.gov record.